NCT00003966View on ClinicalTrials.gov

Defibrotide in Treating Patients With Liver Damage Following Peripheral Stem Cell Transplantation

PHASE2CompletedINTERVENTIONAL
Enrollment

151

Participants

Timeline

Start Date

April 30, 2000

Primary Completion Date

February 28, 2006

Study Completion Date

April 30, 2006

Conditions
Veno-occlusive Disease
Interventions
DRUG

defibrotide

Trial Locations (9)

10021

Memorial Sloan-Kettering Cancer Center, New York

27710

Duke Comprehensive Cancer Center, Durham

91010-3000

City of Hope Comprehensive Cancer Center, Duarte

21231-2410

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore

02115

Children's Hospital Boston, Boston

Dana Farber Cancer Institute, Boston

Massachusetts General Hospital, Boston

02215

Beth Israel Deaconess Medical Center, Boston

98109-1024

Fred Hutchinson Cancer Research Center, Seattle

Sponsors

Collaborators (1)

Jazz Pharmaceuticals
All Listed Sponsors
collaborator

Jazz Pharmaceuticals

INDUSTRY

collaborator

National Cancer Institute (NCI)

NIH

lead

Dana-Farber Cancer Institute

OTHER